Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

NCT01353625

Conditions
Astrocytoma, Blood Protein Disorders, Carcinoma, +52 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

NCT01381692

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

NCT00752895

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States
  • Helen and Harry Gray Cancer Center at Hartford Hospital Hartford, Connecticut, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
View all 125 locations
View Trial Details
Completed

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02406742

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medical College Dr. Feldman's Office New York, United States
View all 24 locations
View Trial Details
Completed

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

NCT02582320

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • U.O.C di Ematologia P.O. "S.Giuseppe Moscati" - 2° piano Aversa, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 47 locations
View Trial Details

Related conditions